Global Quadrivalent Meningococcal Vaccine Market Research Report 2024(Status and Outlook)
Report Overview:
The meningococcal quadrivalent vaccine protects against 4 types of meningococcus: types A, C, Y, and W.
The Global Quadrivalent Meningococcal Vaccine Market Size was estimated at USD 174.20 million in 2023 and is projected to reach USD 245.71 million by 2029, exhibiting a CAGR of 5.90% during the forecast period.
This report provides a deep insight into the global Quadrivalent Meningococcal Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Quadrivalent Meningococcal Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Quadrivalent Meningococcal Vaccine market in any manner.
Global Quadrivalent Meningococcal Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi-Pasteur
Walvax
Chengdu Kanghua Biological Products Co., Ltd.
Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
Beijing Institute of Biological Products Co., Ltd.
CanSino Biological Co., Ltd.
Hualan Biological Vaccine Co., Ltd.
Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
Market Segmentation (by Type)
Polysaccharide Vaccine
Conjugate Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Quadrivalent Meningococcal Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The meningococcal quadrivalent vaccine protects against 4 types of meningococcus: types A, C, Y, and W.
The Global Quadrivalent Meningococcal Vaccine Market Size was estimated at USD 174.20 million in 2023 and is projected to reach USD 245.71 million by 2029, exhibiting a CAGR of 5.90% during the forecast period.
This report provides a deep insight into the global Quadrivalent Meningococcal Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Quadrivalent Meningococcal Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Quadrivalent Meningococcal Vaccine market in any manner.
Global Quadrivalent Meningococcal Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi-Pasteur
Walvax
Chengdu Kanghua Biological Products Co., Ltd.
Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
Beijing Institute of Biological Products Co., Ltd.
CanSino Biological Co., Ltd.
Hualan Biological Vaccine Co., Ltd.
Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
Market Segmentation (by Type)
Polysaccharide Vaccine
Conjugate Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Quadrivalent Meningococcal Vaccine Market
- Overview of the regional outlook of the Quadrivalent Meningococcal Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Quadrivalent Meningococcal Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Quadrivalent Meningococcal Vaccine
1.2 Key Market Segments
1.2.1 Quadrivalent Meningococcal Vaccine Segment by Type
1.2.2 Quadrivalent Meningococcal Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Quadrivalent Meningococcal Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Quadrivalent Meningococcal Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Quadrivalent Meningococcal Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Quadrivalent Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Quadrivalent Meningococcal Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Quadrivalent Meningococcal Vaccine Sales Sites, Area Served, Product Type
3.6 Quadrivalent Meningococcal Vaccine Market Competitive Situation and Trends
3.6.1 Quadrivalent Meningococcal Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Quadrivalent Meningococcal Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 QUADRIVALENT MENINGOCOCCAL VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Quadrivalent Meningococcal Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF QUADRIVALENT MENINGOCOCCAL VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Quadrivalent Meningococcal Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Quadrivalent Meningococcal Vaccine Price by Type (2019-2024)
7 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Quadrivalent Meningococcal Vaccine Market Sales by Application (2019-2024)
7.3 Global Quadrivalent Meningococcal Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Quadrivalent Meningococcal Vaccine Sales Growth Rate by Application (2019-2024)
8 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Quadrivalent Meningococcal Vaccine Sales by Region
8.1.1 Global Quadrivalent Meningococcal Vaccine Sales by Region
8.1.2 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Quadrivalent Meningococcal Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Quadrivalent Meningococcal Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Quadrivalent Meningococcal Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Quadrivalent Meningococcal Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sanofi-Pasteur
9.1.1 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Basic Information
9.1.2 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Overview
9.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Market Performance
9.1.4 Sanofi-Pasteur Business Overview
9.1.5 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine SWOT Analysis
9.1.6 Sanofi-Pasteur Recent Developments
9.2 Walvax
9.2.1 Walvax Quadrivalent Meningococcal Vaccine Basic Information
9.2.2 Walvax Quadrivalent Meningococcal Vaccine Product Overview
9.2.3 Walvax Quadrivalent Meningococcal Vaccine Product Market Performance
9.2.4 Walvax Business Overview
9.2.5 Walvax Quadrivalent Meningococcal Vaccine SWOT Analysis
9.2.6 Walvax Recent Developments
9.3 Chengdu Kanghua Biological Products Co., Ltd.
9.3.1 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.3.2 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.3.4 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine SWOT Analysis
9.3.5 Chengdu Kanghua Biological Products Co., Ltd. Business Overview
9.3.6 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments
9.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
9.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Business Overview
9.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments
9.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
9.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Business Overview
9.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments
9.6 Beijing Institute of Biological Products Co., Ltd.
9.6.1 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.6.2 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.6.4 Beijing Institute of Biological Products Co., Ltd. Business Overview
9.6.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments
9.7 CanSino Biological Co., Ltd.
9.7.1 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.7.2 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.7.4 CanSino Biological Co., Ltd. Business Overview
9.7.5 CanSino Biological Co., Ltd. Recent Developments
9.8 Hualan Biological Vaccine Co., Ltd.
9.8.1 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.8.2 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.8.4 Hualan Biological Vaccine Co., Ltd. Business Overview
9.8.5 Hualan Biological Vaccine Co., Ltd. Recent Developments
9.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
9.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Business Overview
9.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments
10 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET FORECAST BY REGION
10.1 Global Quadrivalent Meningococcal Vaccine Market Size Forecast
10.2 Global Quadrivalent Meningococcal Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Quadrivalent Meningococcal Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Quadrivalent Meningococcal Vaccine Market Size Forecast by Region
10.2.4 South America Quadrivalent Meningococcal Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Quadrivalent Meningococcal Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Quadrivalent Meningococcal Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Quadrivalent Meningococcal Vaccine by Type (2025-2030)
11.1.2 Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Quadrivalent Meningococcal Vaccine by Type (2025-2030)
11.2 Global Quadrivalent Meningococcal Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Quadrivalent Meningococcal Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Quadrivalent Meningococcal Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Quadrivalent Meningococcal Vaccine
1.2 Key Market Segments
1.2.1 Quadrivalent Meningococcal Vaccine Segment by Type
1.2.2 Quadrivalent Meningococcal Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Quadrivalent Meningococcal Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Quadrivalent Meningococcal Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Quadrivalent Meningococcal Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Quadrivalent Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Quadrivalent Meningococcal Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Quadrivalent Meningococcal Vaccine Sales Sites, Area Served, Product Type
3.6 Quadrivalent Meningococcal Vaccine Market Competitive Situation and Trends
3.6.1 Quadrivalent Meningococcal Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Quadrivalent Meningococcal Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 QUADRIVALENT MENINGOCOCCAL VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Quadrivalent Meningococcal Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF QUADRIVALENT MENINGOCOCCAL VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Quadrivalent Meningococcal Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Quadrivalent Meningococcal Vaccine Price by Type (2019-2024)
7 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Quadrivalent Meningococcal Vaccine Market Sales by Application (2019-2024)
7.3 Global Quadrivalent Meningococcal Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Quadrivalent Meningococcal Vaccine Sales Growth Rate by Application (2019-2024)
8 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Quadrivalent Meningococcal Vaccine Sales by Region
8.1.1 Global Quadrivalent Meningococcal Vaccine Sales by Region
8.1.2 Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Quadrivalent Meningococcal Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Quadrivalent Meningococcal Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Quadrivalent Meningococcal Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Quadrivalent Meningococcal Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Sanofi-Pasteur
9.1.1 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Basic Information
9.1.2 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Overview
9.1.3 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Market Performance
9.1.4 Sanofi-Pasteur Business Overview
9.1.5 Sanofi-Pasteur Quadrivalent Meningococcal Vaccine SWOT Analysis
9.1.6 Sanofi-Pasteur Recent Developments
9.2 Walvax
9.2.1 Walvax Quadrivalent Meningococcal Vaccine Basic Information
9.2.2 Walvax Quadrivalent Meningococcal Vaccine Product Overview
9.2.3 Walvax Quadrivalent Meningococcal Vaccine Product Market Performance
9.2.4 Walvax Business Overview
9.2.5 Walvax Quadrivalent Meningococcal Vaccine SWOT Analysis
9.2.6 Walvax Recent Developments
9.3 Chengdu Kanghua Biological Products Co., Ltd.
9.3.1 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.3.2 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.3.3 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.3.4 Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine SWOT Analysis
9.3.5 Chengdu Kanghua Biological Products Co., Ltd. Business Overview
9.3.6 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments
9.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd.
9.4.1 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.4.2 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.4.3 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.4.4 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Business Overview
9.4.5 Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments
9.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd.
9.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Business Overview
9.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments
9.6 Beijing Institute of Biological Products Co., Ltd.
9.6.1 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.6.2 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.6.3 Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.6.4 Beijing Institute of Biological Products Co., Ltd. Business Overview
9.6.5 Beijing Institute of Biological Products Co., Ltd. Recent Developments
9.7 CanSino Biological Co., Ltd.
9.7.1 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.7.2 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.7.3 CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.7.4 CanSino Biological Co., Ltd. Business Overview
9.7.5 CanSino Biological Co., Ltd. Recent Developments
9.8 Hualan Biological Vaccine Co., Ltd.
9.8.1 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.8.2 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.8.3 Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.8.4 Hualan Biological Vaccine Co., Ltd. Business Overview
9.8.5 Hualan Biological Vaccine Co., Ltd. Recent Developments
9.9 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd.
9.9.1 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
9.9.2 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
9.9.3 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Market Performance
9.9.4 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Business Overview
9.9.5 Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments
10 QUADRIVALENT MENINGOCOCCAL VACCINE MARKET FORECAST BY REGION
10.1 Global Quadrivalent Meningococcal Vaccine Market Size Forecast
10.2 Global Quadrivalent Meningococcal Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Quadrivalent Meningococcal Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Quadrivalent Meningococcal Vaccine Market Size Forecast by Region
10.2.4 South America Quadrivalent Meningococcal Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Quadrivalent Meningococcal Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Quadrivalent Meningococcal Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Quadrivalent Meningococcal Vaccine by Type (2025-2030)
11.1.2 Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Quadrivalent Meningococcal Vaccine by Type (2025-2030)
11.2 Global Quadrivalent Meningococcal Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Quadrivalent Meningococcal Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Quadrivalent Meningococcal Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Quadrivalent Meningococcal Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Quadrivalent Meningococcal Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Quadrivalent Meningococcal Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Quadrivalent Meningococcal Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quadrivalent Meningococcal Vaccine as of 2022)
Table 10. Global Market Quadrivalent Meningococcal Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Quadrivalent Meningococcal Vaccine Sales Sites and Area Served
Table 12. Manufacturers Quadrivalent Meningococcal Vaccine Product Type
Table 13. Global Quadrivalent Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Quadrivalent Meningococcal Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Quadrivalent Meningococcal Vaccine Market Challenges
Table 22. Global Quadrivalent Meningococcal Vaccine Sales by Type (Kilotons)
Table 23. Global Quadrivalent Meningococcal Vaccine Market Size by Type (M USD)
Table 24. Global Quadrivalent Meningococcal Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Quadrivalent Meningococcal Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Quadrivalent Meningococcal Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Quadrivalent Meningococcal Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Quadrivalent Meningococcal Vaccine Sales (Kilotons) by Application
Table 30. Global Quadrivalent Meningococcal Vaccine Market Size by Application
Table 31. Global Quadrivalent Meningococcal Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Quadrivalent Meningococcal Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Quadrivalent Meningococcal Vaccine Market Share by Application (2019-2024)
Table 35. Global Quadrivalent Meningococcal Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Quadrivalent Meningococcal Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Quadrivalent Meningococcal Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Quadrivalent Meningococcal Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Quadrivalent Meningococcal Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Basic Information
Table 44. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Overview
Table 45. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sanofi-Pasteur Business Overview
Table 47. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine SWOT Analysis
Table 48. Sanofi-Pasteur Recent Developments
Table 49. Walvax Quadrivalent Meningococcal Vaccine Basic Information
Table 50. Walvax Quadrivalent Meningococcal Vaccine Product Overview
Table 51. Walvax Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Walvax Business Overview
Table 53. Walvax Quadrivalent Meningococcal Vaccine SWOT Analysis
Table 54. Walvax Recent Developments
Table 55. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 56. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 57. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine SWOT Analysis
Table 59. Chengdu Kanghua Biological Products Co., Ltd. Business Overview
Table 60. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments
Table 61. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 62. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 63. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Business Overview
Table 65. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments
Table 66. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 67. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 68. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Business Overview
Table 70. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments
Table 71. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 72. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 73. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Beijing Institute of Biological Products Co., Ltd. Business Overview
Table 75. Beijing Institute of Biological Products Co., Ltd. Recent Developments
Table 76. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 77. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 78. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. CanSino Biological Co., Ltd. Business Overview
Table 80. CanSino Biological Co., Ltd. Recent Developments
Table 81. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 82. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 83. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Hualan Biological Vaccine Co., Ltd. Business Overview
Table 85. Hualan Biological Vaccine Co., Ltd. Recent Developments
Table 86. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 87. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 88. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Business Overview
Table 90. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments
Table 91. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Quadrivalent Meningococcal Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Quadrivalent Meningococcal Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Quadrivalent Meningococcal Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Quadrivalent Meningococcal Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Quadrivalent Meningococcal Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Quadrivalent Meningococcal Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Quadrivalent Meningococcal Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Quadrivalent Meningococcal Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Quadrivalent Meningococcal Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quadrivalent Meningococcal Vaccine as of 2022)
Table 10. Global Market Quadrivalent Meningococcal Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Quadrivalent Meningococcal Vaccine Sales Sites and Area Served
Table 12. Manufacturers Quadrivalent Meningococcal Vaccine Product Type
Table 13. Global Quadrivalent Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Quadrivalent Meningococcal Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Quadrivalent Meningococcal Vaccine Market Challenges
Table 22. Global Quadrivalent Meningococcal Vaccine Sales by Type (Kilotons)
Table 23. Global Quadrivalent Meningococcal Vaccine Market Size by Type (M USD)
Table 24. Global Quadrivalent Meningococcal Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Quadrivalent Meningococcal Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Quadrivalent Meningococcal Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Quadrivalent Meningococcal Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Quadrivalent Meningococcal Vaccine Sales (Kilotons) by Application
Table 30. Global Quadrivalent Meningococcal Vaccine Market Size by Application
Table 31. Global Quadrivalent Meningococcal Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Quadrivalent Meningococcal Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Quadrivalent Meningococcal Vaccine Market Share by Application (2019-2024)
Table 35. Global Quadrivalent Meningococcal Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Quadrivalent Meningococcal Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Quadrivalent Meningococcal Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Quadrivalent Meningococcal Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Quadrivalent Meningococcal Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Quadrivalent Meningococcal Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Basic Information
Table 44. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Product Overview
Table 45. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Sanofi-Pasteur Business Overview
Table 47. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine SWOT Analysis
Table 48. Sanofi-Pasteur Recent Developments
Table 49. Walvax Quadrivalent Meningococcal Vaccine Basic Information
Table 50. Walvax Quadrivalent Meningococcal Vaccine Product Overview
Table 51. Walvax Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Walvax Business Overview
Table 53. Walvax Quadrivalent Meningococcal Vaccine SWOT Analysis
Table 54. Walvax Recent Developments
Table 55. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 56. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 57. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine SWOT Analysis
Table 59. Chengdu Kanghua Biological Products Co., Ltd. Business Overview
Table 60. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments
Table 61. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 62. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 63. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Business Overview
Table 65. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments
Table 66. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 67. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 68. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Business Overview
Table 70. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments
Table 71. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 72. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 73. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Beijing Institute of Biological Products Co., Ltd. Business Overview
Table 75. Beijing Institute of Biological Products Co., Ltd. Recent Developments
Table 76. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 77. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 78. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. CanSino Biological Co., Ltd. Business Overview
Table 80. CanSino Biological Co., Ltd. Recent Developments
Table 81. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 82. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 83. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Hualan Biological Vaccine Co., Ltd. Business Overview
Table 85. Hualan Biological Vaccine Co., Ltd. Recent Developments
Table 86. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Basic Information
Table 87. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Product Overview
Table 88. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Business Overview
Table 90. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments
Table 91. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 92. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 93. North America Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 94. North America Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 95. Europe Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 96. Europe Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 97. Asia Pacific Quadrivalent Meningococcal Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 98. Asia Pacific Quadrivalent Meningococcal Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 99. South America Quadrivalent Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 100. South America Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 101. Middle East and Africa Quadrivalent Meningococcal Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 102. Middle East and Africa Quadrivalent Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 103. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 104. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 105. Global Quadrivalent Meningococcal Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 106. Global Quadrivalent Meningococcal Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 107. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Quadrivalent Meningococcal Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Quadrivalent Meningococcal Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Quadrivalent Meningococcal Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Quadrivalent Meningococcal Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Quadrivalent Meningococcal Vaccine Market Size by Country (M USD)
Figure 11. Quadrivalent Meningococcal Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Quadrivalent Meningococcal Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Quadrivalent Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Quadrivalent Meningococcal Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Quadrivalent Meningococcal Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Quadrivalent Meningococcal Vaccine Market Share by Type
Figure 18. Sales Market Share of Quadrivalent Meningococcal Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Quadrivalent Meningococcal Vaccine by Type in 2023
Figure 20. Market Size Share of Quadrivalent Meningococcal Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Quadrivalent Meningococcal Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Quadrivalent Meningococcal Vaccine Market Share by Application
Figure 24. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application in 2023
Figure 26. Global Quadrivalent Meningococcal Vaccine Market Share by Application (2019-2024)
Figure 27. Global Quadrivalent Meningococcal Vaccine Market Share by Application in 2023
Figure 28. Global Quadrivalent Meningococcal Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Quadrivalent Meningococcal Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Quadrivalent Meningococcal Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Quadrivalent Meningococcal Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Quadrivalent Meningococcal Vaccine Sales Market Share by Region in 2023
Figure 44. China Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Quadrivalent Meningococcal Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Quadrivalent Meningococcal Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Quadrivalent Meningococcal Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Quadrivalent Meningococcal Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Quadrivalent Meningococcal Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Quadrivalent Meningococcal Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Quadrivalent Meningococcal Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Quadrivalent Meningococcal Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Quadrivalent Meningococcal Vaccine Market Size by Country (M USD)
Figure 11. Quadrivalent Meningococcal Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Quadrivalent Meningococcal Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Quadrivalent Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Quadrivalent Meningococcal Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Quadrivalent Meningococcal Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Quadrivalent Meningococcal Vaccine Market Share by Type
Figure 18. Sales Market Share of Quadrivalent Meningococcal Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Quadrivalent Meningococcal Vaccine by Type in 2023
Figure 20. Market Size Share of Quadrivalent Meningococcal Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Quadrivalent Meningococcal Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Quadrivalent Meningococcal Vaccine Market Share by Application
Figure 24. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Application in 2023
Figure 26. Global Quadrivalent Meningococcal Vaccine Market Share by Application (2019-2024)
Figure 27. Global Quadrivalent Meningococcal Vaccine Market Share by Application in 2023
Figure 28. Global Quadrivalent Meningococcal Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Quadrivalent Meningococcal Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Quadrivalent Meningococcal Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Quadrivalent Meningococcal Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Quadrivalent Meningococcal Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Quadrivalent Meningococcal Vaccine Sales Market Share by Region in 2023
Figure 44. China Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Quadrivalent Meningococcal Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Quadrivalent Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Quadrivalent Meningococcal Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Quadrivalent Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Quadrivalent Meningococcal Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Quadrivalent Meningococcal Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Quadrivalent Meningococcal Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Quadrivalent Meningococcal Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Quadrivalent Meningococcal Vaccine Market Share Forecast by Application (2025-2030)
